Author

S. Anzick

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 4 Organism:rat· 3 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

C. Martens· 4 shared G. Saturday· 4 shared N. van Doremalen· 4 shared V. Munster· 4 shared A. Okumura· 3 shared B. Smith· 3 shared B. Williamson· 3 shared E. de Wit· 3 shared

Activity by Year

2020-2021 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersMicrobiology

C. Martens

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Subtle differences in the pathogenicity of SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in rhesus macaques

V. Munster, M. Flagg, M. Singh, B. Williamson, F. Feldmann, L. Perez-Perez, B. Brumbaugh, M. Holbrook, D. Adney, A. Okumura, P. Hanley, B. Smith, J. Lovaglio, S. Anzick, C. Martens, , E. de Wit

This study compares the pathogenicity of SARS-CoV-2 variants B.1.1.7 and B.1.351 in rhesus macaques, finding differences in clinical outcomes and immune responses.

bioRxiv · May 7, 2021Microbiology

ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7 1 disease

R. Fischer, N. van Doremalen, D. Adney, C. Yinda, J. Port, M. Holbrook, J. Schulz, B. Williamson, T. Thomas, K. Barbian, S. Anzick, S. Ricklefs, B. Smith, D. Long, C. Martens, , V. Munster

This study shows that the ChAdOx1 nCoV-19 vaccine protects Syrian hamsters from SARS-CoV-2 B.1.1.7 and B.1.351 variants, preventing weight loss, lung lesions, and viral replication.

bioRxiv · Mar 11, 2021Microbiology

Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces shedding of SARS-CoV-2 D614G in rhesus macaques

N. van Doremalen, J. Purushotham, J. Schulz, M. Holbrook, T. Bushmaker, A. Carmody, J. Port, K. C. Yinda, A. Okumura, G. Saturday, F. Amanat, F. Krammer, P. Hanley, B. Smith, J. Lovaglio, , V. Munster

This study shows intranasal ChAdOx1 nCoV-19 vaccination reduces SARS-CoV-2 shedding in animal models but not pneumonia protection.

bioRxiv · Jan 9, 2021 · PreprintMicrobiology

Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2

B. Williamson, F. Feldmann, B. Schwarz, K. Meade-White, D. Porter, J. Schulz, N. van Doremalen, I. Leighton, C. K. Yinda, L. Perez-Perez, A. Okumura, J. Lovaglio, P. Hanley, G. Saturday, C. Bosio, , E. de Wit

This study shows remdesivir reduces SARS-CoV-2 viral load and lung damage in rhesus macaques when administered early in infection.

bioRxiv · Apr 15, 2020Microbiology